Back to Search Start Over

Adaptation of dose-prescription for vestibular schwannoma radiosurgery taking body contouring method and heterogeneous material into account.

Authors :
Fager M
Gubanski M
Carlsson Tedgren Å
Benmakhlouf H
Source :
Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2025 Feb 26; Vol. 64, pp. 319-325. Date of Electronic Publication: 2025 Feb 26.
Publication Year :
2025

Abstract

Background: Majority of vestibular schwannoma (VS) patients have undergone gamma-knife radiosurgery (GKRS) with favorable results. Clinical evidence is derived from doses calculated with a type-a algorithm, which in this case assumes all material to be water. A type-b algorithm (Convolution algorithm [CA]) taking tissue heterogeneity into account is available. Historically, body contour is defined using a 16-point approximation, whereas modern softwares generate the body from Magnetic Resonance Imaging (MRI). The accuracy in dose-calculation algorithms (DCA) and contouring method (CM) will have a significant influence in the relation between clinical outcome and dosimetric data. The objective was to investigate the impact of DCA and CMs on dose distribution while preserving treatment conditions.<br />Methods: Treatment plans for 16 VS patients were recalculated in terms of DCA and CM. The difference in the dose covering 99% of the VS (DVS99%) depending on CM and DCA was estimated. The difference in DVS99% was used to adopt the prescription of new CA-based plans. CA-plans were recalculated to TMR10 to evaluate clinical treatability, as clinical evidence is derived from TMR10-doses.<br />Results: Both CM and DCA had a significant impact on the dose to VS and surrounding structures. CM altered the doses homogenously by 2.1-3.3%, whereas DCA heterogeneously by 5.0-10.7%. An increase of 9.1[8.1, 10.0]% was found for DVS99% and the CA-plans recalculated into TMR10 resulted in clinically treatable plans.<br />Interpretation: We conclude that transferring to more modern algorithms that take tissue heterogeneity into account heterogeneously alter dose distributions. This work establishes a safe pathway to adopt prescription dose for VS while preserving clinical treatability.

Details

Language :
English
ISSN :
1651-226X
Volume :
64
Database :
MEDLINE
Journal :
Acta oncologica (Stockholm, Sweden)
Publication Type :
Academic Journal
Accession number :
40008908
Full Text :
https://doi.org/10.2340/1651-226X.2025.41924